While the GLP-1 treatments worked well in experiments on ... the weight-loss medication market could reach $100 billion by ...

The Lasker-DeBakey Award for clinical medical research went to three scientists for their work on GLP-1, the hormone that led ...

I can’t help but say that we know this year, being discussed was Joel Habener and the GLP-1 work coming out of Massachusetts ... David Baulcombe, who shared the Lasker prize with you, wasn ...

Joel Habener of Massachusetts General Hospital and Svetlana Mojsov of The Rockefeller University, who are being honored with ...

PHILADELPHIA — The use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) is associated with a significant decrease in the risk for early-onset colorectal cancer (EO-CRC) in patients with ...

Weight-Loss Surgeries Decline 25% as More Americans Turn to GLP-1 Meds By Ernie Mundell HealthDay Reporter FRIDAY, Oct. 25, 2024 (HealthDay News) -- As the popularity of GLP-1 meds like Wegovy and ...

Starting in the 1990s, Knudsen, the head of GLP-1 therapeutics at Novo Nordisk, and her team built on these breakthroughs to ...